Dr Dania Movia
SENIOR RESEARCH FELLOW AT TRINITY COLLEGE DUBLIN.
Dr Helena Kandarova
Helena’s professional scientific interest is focusing on the development, validation and implementation of in vitro methods for reduction & replacement of in vivo tests for topical toxicity testing of chemicals, cosmetics, pesticides and medical devices. She has been involved or directly managed international projects aiming at the evaluation and validation of 3D reconstructed human tissue models replacing testing in animals.
Helena completed her PhD thesis on the „ Use of Reconstructed human tissue models in regulatory toxicology“ in 2006 at Freie Universität in Berlin. Her PhD thesis was largely supported by ZEBET at the Federal Institute of Risk Assessment (BfR). After finishing her PhD, she joined MatTek Corporation, USA in 2007 in the position of Senior Scientist and General Acting Manager for EU and since 2009 - 2018 she acted also as Exectutive Director of MatTek In Vitro Life Science Laboratories, located in the EU.
Helena is board member of several professional toxicology platforms, associate editor at three toxicology-oriented journals and she actively contributes to in vitro toxicology and concept of 3Rs via her expert work at the OECD and at national expert platforms. She co-authored over 40 publications and achieved more than 1000 cited references. She was president of the EUROTOX 2017 Congress and obtained several awards related to in vitro toxicology and 3Rs.
Dr Pascale Guillot
Non Clinical Senior Lecturer
"Replacing the use of animals to study bone fragility"
Dr Marta Rucka
Product Manager, Cellular Analysis.
"Factors to Consider for Developing In Vitro Cytotoxicity Assays to Replace Animal Testing"
Dr Jan Turner
Safer Medicines Trust
"HUMAN RELEVANT IN VITRO MODELS – BARRIERS, INITIATIVES AND PROGRESS TOWARDS REPLACING ANIMAL METHODS IN DRUG DISCOVERY"